Similar Articles
191 Targeting inflammation in diabetes: Newer therapeutic options
192 Benefits of healthy adipose tissue in the treatment of diabetes
193 Nanotechnological approaches in diabetes treatment: A new horizon
194 Relevance of α-defensins (HNP1-3) and defensin β-1 in diabetes
195 Transplant options for patients with type 2 diabetes and chronic kidney disease
196 Evidence for altered thiamine metabolism in diabetes: Is there a potential to oppose gluco- and lipotoxicity by rational supplementation?
197 Adrenomedullin and diabetes
198 Diabetes, sleep apnea, obesity and cardiovascular disease: Why not address them together?
199 Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease
200 Origin and therapy for hypertriglyceridaemia in type 2 diabetes
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA